U of T researchers target neurogenesis in new approach to treat Parkinson’s disease
Medicine by Design-funded research points toward a new treatment approach
Discovery to Impact: The Medicine by Design Project Showcase in pictures
Full day event celebrates eight years of success and explores future directions
Medicine by Design researcher featured in media for MS Awareness month
Cutting-edge neural reprogramming strategy could transform the future of MS treatment
Several Medicine by Design-funded projects to be further advanced by Stem Cell Network investment
The Medicine by Design-funded researchers awarded come from disciplines that include stem cell biology, neuroscience and biomedical engineering.
Medicine by Design-funded researchers selected for Kick-Start Innovation Program
Program selects inaugural incubator companies
Medicine by Design announces two new Pivotal Experiment Fund projects
Projects to impact autoimmune, intestinal and degenerative eye diseases
Enabling long-lasting cell therapy for diabetes without injection
Is immunoengineering the key to ensuring that cell therapies can treat disease?
Medicine by Design-funded researchers generate cells that will impact treatments for bile duct disorders as a result of cystic fibrosis
Newly-generated cells may lead to a deeper understanding of bile duct disease and be a powerful tool for finding new treatments.
New Medicine by Design-funded method for testing muscle repair in a dish to impact development of stem cell-based therapies
Scientists at the University of Toronto have discovered a novel way to test self-repair of skeletal muscle, a method with the potential to accelerate treatments for diseases like muscular dystrophy.
Medicine by Design-funded research finds transplanting insulin-producing cells with blood vessels may help reverse diabetes
Researchers have engineered a new method to improve the survival and potency of cell transplants to treat diabetes.
Medicine by Design’s Pivotal Experiment Fund invests $1 million in four research teams to bridge the “valley of death” funding gap
Funding gives cutting-edge regenerative medicine concepts impacting heart disease, lung transplantation, degenerative brain disease and end-stage liver disease a pathway to clinical translation.
Growing mini-organs to study brain development and disease
This “revolutionizing biology” offers the promise of new treatments for diseases and conditions including inflammatory bowel disease and autism spectrum disorder.
Advancing stem cell manufacturing technologies
Cross-cutting research makes promising strides toward clinical testing
New research shows diabetes drug could provide brain protection to children who get radiation for brain tumours
Thanks to funding from Medicine by Design, a University of Toronto scientist and her team are closer to finding a way to protect the brain from damage for children who must be treated with cranial radiation.
Pivotal Experiment Fund to accelerate Medicine by Design-funded research toward impact
Medicine by Design's $4-million Pivotal Experiment Fund aims to bridge one of the critical gaps in the “valley of death” between a research discovery and a translatable therapy.